Astec LifeSciences Limited recorded an annual operating revenue of approximately ₹453.14 crore (or roughly ₹44,814.56 lakhs) for the financial year. This reflects a year-on-year revenue recovery of roughly 17.13 percent driven by strong domestic performance and expanding contract manufacturing operations. The company's revenue streams are anchored heavily in the production of specialty agrochemical active ingredients, triazole fungicides, and custom contract development and manufacturing solutions.